Cost effectiveness/economic

Latest Articles

Research Article
Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease
Melanie D. Whittington, Jonathan D. Campbell, David Rind, et al.

Neurology January 12, 2022
Research Methods in Neurology
Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of Aducanumab
Jonathan D Campbell, Melanie D. Whittington, Steven D Pearson

Neurology January 12, 2022
Research Article
Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor–Associated Intracerebral Hemorrhage
Carlin C. Chuck, Daniel Kim, Roshini Kalagara, et al.

Neurology September 23, 2021
Editorial
Andexanet Alfa for Factor Xa Inhibitor–Associated Intracerebral HemorrhageDoes a Specific Reversal Agent Justify Its Cost?
Nikhil Patel, Nicholas A. Morris

Neurology September 23, 2021